Want to see JP:4578 full AI Analyst Report?

Otsuka Holdings Co (4578) Price & Analysis

2 Followers

4578 Stock Chart & Stats

¥11155.00

¥60.00(0.53%)

At close: Jul 28 4:00 PM EDT

¥11155.00

¥60.00(0.53%)

Day’s Range― - ―

52-Week Range¥7,223.00 - ¥12,525.00

Previous CloseN/A

Volume1.54M

Average Volume (3M)1.11M

Market Cap

¥5.86T

Enterprise Value¥5.48M

Total Cash (Recent Filing)¥469.55B

Total Debt (Recent Filing)¥194.20B

Price to Earnings (P/E)14.4

Beta0.68

Next Earnings

Nov 04, 2026

EPS Estimate

177.76

Next Dividend Ex-DateN/A

Dividend Yield1.53%

Share Statistics

EPS (TTM)768.34

Shares Outstanding542,988,900

10 Day Avg. Volume977,130

30 Day Avg. Volume1,112,043

Financial Highlights & Ratios

PEG Ratio1.60

Price to Book (P/B)1.55

Price to Sales (P/S)1.91

P/FCF Ratio14.90

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥13,431.25

Price Target Upside20.41% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

EPS Forecast (FY)615.37

Revenue Forecast (FY)¥2.62T

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent top-line expansion (TTM revenue up vs prior year and ~9% growth) indicates durable demand across pharmaceuticals and consumer health. A steady revenue base supports multi-period investment in R&D, marketing and distribution, reducing reliance on single product cycles and underpinning sustained cash generation.

Margin ImprovementHigh gross margins and materially improved net margins reflect structural pricing power and operating leverage in core franchises. Sustained margin expansion increases internal funding for R&D and capex, strengthens return on equity, and provides a buffer against volume or pricing pressure over the medium term.

Balance Sheet StrengthVery low leverage and steadily expanding equity create strong financial flexibility for R&D, strategic M&A or shareholder returns. A conservative balance sheet reduces refinancing and liquidity risk, enabling stable capital allocation and resilience across industry cycles over the next several quarters.

Bears Say

Weak Cash ConversionOperating cash flow has converted to only ~59% of reported earnings, suggesting working-capital timing or non-cash accounting elements. Persistent cash conversion shortfalls can limit free cash available for reinvestment or payout, increase sensitivity to working-capital swings, and constrain capital allocation flexibility.

Earnings VolatilityAlthough margins improved recently, earlier years showed materially lower and volatile profitability, implying earnings depend on product mix, one-offs, or timing. This uneven track record increases uncertainty about sustaining current profit levels through patent expiries, launch cycles, or macroeconomic shifts.

Pharma Structural RisksThe business remains exposed to structural pharma risks: patent cliffs, reimbursement changes and pricing pressure across markets. These durable external factors can sharply alter revenue trajectories if exclusivity lapses or reimbursement rules change, making long-term visibility contingent on successful launches and lifecycle management.

Otsuka Holdings Co News

Otsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an update. Otsuka reported new Phase 3 VISIONARY data showing...

2d ago

Otsuka Holdings Continues Share Buybacks Under ¥50 Billion Authorization

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an update. Otsuka Holdings has continued its share repurchase program...

3d ago

Otsuka Lifts 2026 Earnings Outlook and Raises Dividends on Strong Drug Sales

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an update. Otsuka Holdings has sharply raised its full-year 2026...

6d ago

Otsuka Holdings Delivers Strong Half-Year Earnings and Lifts 2026 Dividend Forecast

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an announcement. Otsuka Holdings reported strong results for the six-month...

6d ago

Is OTSKF a Buy, Before Earnings?

Otsuka Holdings Co (OTSKF) is scheduled to report 2nd quarter earnings on 07/31/2026. Regarding Q2 estimates, Wall Street...

8d ago

Otsuka Lifts First-Half 2026 Earnings Forecast on Strong Drug Sales and Weak Yen

An announcement from Otsuka Holdings Co ( ($JP:4578) ) is now available. Otsuka Holdings revised its consolidated forecast...

9d ago

Otsuka’s VOYXACT Achieves Key Phase 3 Success in IgA Nephropathy, Bolstering Long-Term Growth Strategy

Otsuka Holdings Co ( ($JP:4578) ) has provided an announcement. Otsuka announced positive topline results from the Phase...

1M ago

Otsuka Holdings Advances Share Buyback, Repurchases ¥29.9 Billion in Stock

Otsuka Holdings Co ( ($JP:4578) ) has issued an update. Otsuka Holdings has continued executing its share repurchase...

1M ago

Otsuka’s VOYXACT Shows Kidney Function Preservation in Phase 3 IgA Nephropathy Trial

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an update. Otsuka reported positive interim Phase 3 data showing...

2M ago

Otsuka Advances ¥50 Billion Share Buyback, Repurchasing Over 2 Million Shares

Otsuka Holdings Co ( ($JP:4578) ) just unveiled an announcement. Otsuka Holdings Co., Ltd. has been executing a...

2M ago

Otsuka upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Otsuka (OTSKY) to Overweight from Equal Weight with a price target of 12,600 yen, up...

6M ago

Cullinan Therapeutics and partners initiate NDA application for zipalertinib

Cullinan Therapeutics (CGEM) and Otsuka Holdings (OTSKF) subsidiaries Taiho Oncology and Taiho Pharmaceutical have initiated the rolling submission...

9M ago

U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz

The major averages were sharply higher following the latest U.S. jobs data, which was better than expected, easing...

1y ago

Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data

Shares of Vera Therapeutics (VERA) dropped nearly 30% in premarket trading after rival Otsuka (OTSKY) presented results from...

1y ago

VERA

4578 FAQ

What was Otsuka Holdings Co Ltd’s price range in the past 12 months?

Otsuka Holdings Co Ltd lowest stock price was ¥7223.00 and its highest was ¥12525.00 in the past 12 months.

What is Otsuka Holdings Co Ltd’s market cap?

Otsuka Holdings Co Ltd’s market cap is ¥5.86T.

When is Otsuka Holdings Co Ltd’s upcoming earnings report date?

Otsuka Holdings Co Ltd’s upcoming earnings report date is Nov 04, 2026 which is in 90 days.

How were Otsuka Holdings Co Ltd’s earnings last quarter?

Otsuka Holdings Co Ltd released its earnings results on Jul 31, 2026. The company reported ¥222.76 earnings per share for the quarter, beating the consensus estimate of ¥163.92 by ¥58.84.

Is Otsuka Holdings Co Ltd overvalued?

According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Otsuka Holdings Co Ltd pay dividends?

Otsuka Holdings Co Ltd pays a Semiannually dividend of ¥100 which represents an annual dividend yield of 1.53%. See more information on Otsuka Holdings Co Ltd dividends here

What is Otsuka Holdings Co Ltd’s EPS estimate?

Otsuka Holdings Co Ltd’s EPS estimate is 177.76.

How many shares outstanding does Otsuka Holdings Co Ltd have?

Otsuka Holdings Co Ltd has 542,988,900 shares outstanding.

What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?

Otsuka Holdings Co Ltd reported an EPS of ¥222.76 in its last earnings report, beating expectations of ¥163.92. Following the earnings report the stock price went down -1.813%.

Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?

Currently, no hedge funds are holding shares in JP:4578

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Otsuka Holdings Co Ltd

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Otsuka Holdings Co (4578) Earnings & Revenues

Historic Earnings Reports

4578 Stock 12 Month Forecast

Average Price Target

¥13,431.25

▲(20.41% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7352":"¥7,352","15701":"¥15,701","9439.25":"¥9,439.3","11526.5":"¥11,526.5","13613.75":"¥13,613.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥16K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13431.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥13K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11000,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥11K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7352,9439.25,11526.5,13613.75,15701],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11100,11453.846153846154,11807.692307692309,12161.538461538461,12515.384615384615,12869.23076923077,13223.076923076924,13576.923076923078,13930.76923076923,14284.615384615385,14638.461538461539,14992.307692307691,15346.153846153848,{"y":15700,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11100,11279.326923076924,11458.653846153846,11637.98076923077,11817.307692307691,11996.634615384615,12175.961538461539,12355.288461538461,12534.615384615385,12713.942307692309,12893.26923076923,13072.596153846154,13251.923076923076,{"y":13431.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11100,11092.307692307691,11084.615384615385,11076.923076923076,11069.23076923077,11061.538461538461,11053.846153846154,11046.153846153846,11038.461538461539,11030.76923076923,11023.076923076924,11015.384615384615,11007.692307692309,{"y":11000,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7353.695,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7823.038,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8153.353,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8256.884,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8564.52,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8815.991,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9170.697,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10377.892,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11426.112,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11147.912,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11326.755,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10665,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11100,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >